This is a paid clinical trial advertisement.
Dr. Steve Treon of the Bing Center for Waldenstrom’s Macroglobulinemia presents timely updates in the treatment of WM with a focus on the newly FDA approved Zanubrutinib.
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Getting a diagnosis of WM can feel overwhelming. You have questions, we have answers! Tap in to our comprehensive resources about this rare disease.
We are here to support you throughout your journey living with Waldenstrom macroglobulinemia. Remember, with the IWMF, you are never alone.
When you join the IWMF, you become a member of an international community of people affected by Waldenstrom macroglobulinemia.
BREAKING NEWS The IWMF is excited to share that the U.S. Food and Drug Administration (FDA) has approved the use of Zanubrutinib for the treatment of WM. From...
To achieve its strategic visions, the IWMF recognizes it is vital to provide funding to support the career development of next-generation researchers for WM....
Founded in 2001, Charity Navigator is the nation’s largest and most-utilized evaluator of charities. To help donors decide which non-profits are worthy...
The latest Waldenstrom's Weekly is OUT! Get the all the info on the IWMF Ed Forum on October 28th & 29th. Links to the videos from our workshops on October 6th & October 13th are now available, get them HERE! https://iwmf.com/the-waldenstroms-weekly-29/
#waldenstrom
The Waldenstrom's Weekly is OUT! Watch videos from our Ed Forum Workshops. Download resources.
Register NOW for October 28 & 29 the Ed Forum.
View on our website: http://ow.ly/HFQf50GspTf
#waldenstom #bloodcancerawareness
#MedicareOE starts today! For everything you NEED to know before enrolling, see @TriageCancer’s Cancer Finances module on Medicare: https://bit.ly/cf-medicare
';
